Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Elacestrant|DRUG: Onapristone
Sponsor: Context Therapeutics Inc.